Tag: cancer

Chinese doctor accused of stealing confidential US-funded cancer research

A Chinese doctor was busted at a Texas airport for allegedly attempting to smuggle US-funded cancer research back to his home country – and could face federal charges for the brazen theft.

Yunhai Li, 35, was nabbed at George Bush Intercontinental Airport in Houston on July 9 after border patrol discovered the sensitive confidential medical records on his laptop during an inspection ahead of his flight to China, the Harris County District Attorney’s Office announced Monday.

The Chinese national, who was employed as a researcher at MD Anderson Cancer Center since 2022, was reportedly working on a vaccine to prevent breast cancer from spreading before abruptly quitting on July 1 and uploading the nearly-completed research to a Chinese server on his computer.

“Houston is proudly home to some of the most groundbreaking medical institutions in the world – publicly funded centers that are saving lives each day thanks to their innovative research,” District Attorney Sean Terre said in a statement.

“We have zero tolerance for any attempts that hurt our nation and our community’s ability to pioneer critical medical breakthroughs.”

Keep reading

Cancer Patient Denied Treatment Because of Her Conservative Christian Views

An Oregon hospital refused a Catholic cancer patient treatment because she voiced her views on “transgenderism.”

The staff at the Oregon Health and Science University (OHSU) disregarded Marlene Barbera’s concerns when she commented on the office’s prominently-displayed “transgender” flag. After she had a disagreement over the phone with a staff member, the clinic dropped her as a patient, informing her in an email:

“Effective immediately, you are discharged from receiving medical care at the Richmond Family Medicine Clinic. This action is being taken because of ongoing disrespectful and hurtful remarks about our LGBTQ community and staff… Please note that you are also now dismissed from all OHSU Family Medicine clinics, including Immediate Care clinics.”

In a message to her doctor last year, Barbera had written this:

I have been threatened on Twitter by trans activists with rape and death — so it is daunting to go for medical treatment with that banner proclaiming that what I am, an adult human female, is a mere opt-in category for any gender non-conforming male and not a reality. May I please have a telephone appointment to discuss how I may access your medical care without walking under a banner that seeks to negate all I am?

Barbera thought the message was private, but it was shared with other staff. When she tried to leave a message for her doctor about her medical situation, the receptionist refused and insisted she make an appointment. When she called back, she was still refused service.

“I asked, guessing ‘Did I hurt the trans person’s feelings?’ And the receptionist took offense to the question, asking ‘What did you say?’ slowly and with great emphasis,” Barbera told Reduxx.

A few weeks later, on June 29, the practice manager, Stein Berger, messaged her to say that she had made “transphobic remarks” that harmed the staff of the “inclusive” clinic. That day, the clinic notified her that she could no longer get care at the clinic, effective July 29.

Keep reading

Biden Looks Completely Lost at National Bar Association Gala, Angrily Shouts, Trashes Trump, Stumbles Through Remarks

Joe Biden took the stage at the National Bar Association’s 100th annual gala in at the Hyatt in Chicago on Thursday night.

The 82-year-old looked completely lost as he arrived to the event. Biden had to be escorted to his seat.

This is one of Joe Biden’s rare public appearances since announcing he has an aggressive form of prostate cancer that spread to his bones.

Biden stumbled through his remarks, heavily slurred and trashed the Trump Administration in his speech to black lawyers and judges.

Keep reading

Area 51 staff ‘killed by invisible enemy’ while working on top-secret projects

A group of US Air Force veterans has gone public with their story about how an ‘invisible enemy’ at the top-secret base Area 51 left them with cancer.

The former security guards at the Nevada Test and Training Range (NTTR), a classified site that houses Area 51, have claimed that the US government betrayed them and essentially handed them a death sentence without their knowledge.

Their claims stemmed from the revelation that NTTR was built in the 1970s on an area of land that was found to be contaminated with radiation from years of nuclear testing in the area.

However, that 1975 report from the US Energy Research and Development Administration also said it would ‘be against the national interest’ to stop the military’s secret projects at the site.

David Crete, a former Air Force Sergeant who worked at NTTR from 1983 through 1987, said that over 490 of his fellow workers have died of severe illnesses since being stationed at the secret facility.

Making matters worse, the US Department of Veterans Affairs has refused to cover their medical care because none of the surviving veterans can prove they were exposed to radiation near Area 51.

That’s because their work was so top secret, all records of their activities have been marked as ‘data masked.’

‘I have brain atrophy. The left side of my brain is shrinking and dying. That’s not too bad. I’m one of the healthy ones,’ Crete told the House Veterans Affairs Committee in April while lobbying for legislation to support the Area 51 veterans.

Keep reading

Johnson & Johnson Lead Scientist and Executive Admit Baby Powder Contained ‘Cancer-Causing Heavy Metals’

The O’Keefe Media Group on Friday released undercover video of a Johnson & Johnson lead scientist and executive admit that baby power contained cancer causing heavy metals.

This is the second undercover video in OMG’s series exposing Johnson & Johnson.

Joshua Rys, a Regulatory Affairs Scientist who managed Johnson & Johnson’s baby products spilled the truth to an OMG undercover journalist.

“When I started, actually I started working on the consumer group. Johnson’s was one of my brands. So I managed all the baby products. So actually, when that all happened, I was working on that,” said Joshua Rys.

Rys continued, “It wasn’t actually the product itself, it was an impurity. So naturally talc comes from mines, and the mines don’t have, I guess, 100 percent accurate standards. So the heavy metals, it’s not the talc itself that gives you the cancer, it’s the heavy metals that are in there.”

David Altman, Executive & Senior Clinical Analyst at Johnson & Johnson, said, “This is not your father’s J&J… they don’t really give a sh*t about people.”

Keep reading

Cancer Patients Recover By Taking Repurposed Anti-Parasitic Drugs

Joe Tippens never planned to discover a potential remedy that he credits with saving his life and thrust him into the spotlight among notable cancer survivors. The 67-year-old businessman told The Epoch Times he just wanted to beat a type of cancer with an extremely low survival rate.

In August 2016, Tippens was diagnosed with small cell lung cancer with a fist-sized tumor. After undergoing chemotherapy and radiation five times a week in Houston, the large tumor in his left lung was eliminated. However, Tippens said the treatments came closer to killing him than curing him.

When he returned home to Oklahoma after the New Year, he received devastating news. His oncologist told him he had zero chance of surviving for more than a few months.

“In January of 2017, my PET scan lit up like a Christmas tree and I had wide metastasis everywhere, including in my neck, bones, pancreas, and liver,” Tippens said.

Finding a Lifeline

Facing a prognosis of three months to live, Tippens heard an intriguing story from a veterinarian he knew: A scientist with terminal cancer reportedly cured her lab mice and then herself using fenbendazole, an antiparasitic drug.

The story was the beginning of what eventually became the “Joe Tippens Protocol.”

Fenbendazole, used for 30 years to treat intestinal parasites in animals, has not received U.S. Food and Drug Administration (FDA) approval for human use, meaning doctors cannot prescribe it for people. However, with a terminal diagnosis and nothing to lose, Tippens decided to try it alongside his conventional treatments.

Tippens found that Panacur, a trade name for fenbendazole, was sold over the counter at outlets that carry veterinary medications.

Starting in the third week of January 2017, Tippens began taking the canine medication, Panacur, 1 gram per day for three consecutive days per week. After four days without the medication, which contains about 222 milligrams of fenbendazole per gram, he would repeat his three-day routine. Three months later, Tippens was cancer-free.

His protocol also included Theracurmin, a form of the active compound in turmeric, and CBD, an extract of cannabis which does not cause intoxication.

Keep reading

COVID boosters correlate with worse survival rates for cancer with third-most deaths: study

The Trump administration is getting pulled in opposite directions on its COVID-19 vaccine policy, sued by mainstream American medical associations for removing jab recommendations for healthy children and healthy pregnant women and pressured by jab opponents to further restrict the novel therapeutics, which continue to be mandated in some settings.

Now public health officials are faced with new evidence the jabs accelerate the cancer with the third-most deaths in the U.S and a five-year relative survival rate of 13.3%, which killed civil rights activist and Congressman John Lewis in 2020.

Researchers analyzing why pancreatic cancer survival rates at their Japanese hospital declined in 2022 and 2023, after years of steady increases, found a statistically significant connection between the number of mRNA doses taken by those patients and how quickly they died, even when considering “tumor, node, metastasis” (TNM) factors, surgery and chemotherapy.

Taking as little as the primary series and booster, which the Biden administration rushed through approval over the protests of its lead vaccine reviewers, is “associated with poorer overall survival in patients with PC,” the Miyagi Cancer Center researchers concluded in the peer-reviewed journal Cancers, published by Swiss open-access publisher MDPI. 

They emphasize that “high levels of IgG4, induced by vaccination, correlate with a detrimental prognosis in these patients” — another example of the so-called antibody class switch documented in global research, in which people with three or more jabs start to produce far more antibodies that tolerate rather than neutralize pathogens.

Former National Institute of Allergy and Infectious Diseases Director Dr. Anthony Fauci’s staffer wrote one of those class-switch papers, which was edited by a Pfizer scientist.

Keep reading

Study: CBD Inhibits Osteosarcoma by Targeting Tumor-Driving Inflammation

“Osteosarcoma remains a therapeutic challenge due to its aggressive behavior and high metastatic potential, necessitating exploration of novel treatment modalities”, states the study’s abstract. “Cannabidiol (CBD), a non-psychoactive phytocannabinoid with emerging anticancer properties, has shown promise in preclinical cancer models. However, its mechanisms of action in osteosarcoma remain incompletely understood.”

With that in mind, “This study systematically investigates the antitumor effects of CBD on osteosarcoma and elucidates its molecular targets within the TNF-α/NF-κB/CCL5 signaling axis.”

Conducted by researchers at Shandong University and Harbin Medical University, researchers used cell-based assays and a mouse model, finding that CBD suppressed osteosarcoma cell proliferation, migration, and invasion, while also reducing tumor growth in vivo.

The team identified that CBD binds directly to the NF-κB subunit p65, blocking its ability to activate transcription of the chemokine CCL5. This disruption also interfered with a previously unrecognized positive feedback loop between p65 and CCL5, which helps sustain inflammatory signaling in osteosarcoma cells. By targeting this loop, CBD not only inhibited tumor-promoting inflammation but also weakened the cancer’s ability to proliferate and spread.

The researchers used a combination of molecular docking, protein-binding assays, and gene expression analysis to confirm CBD’s direct interaction with the p65 protein and its downstream effects.

Keep reading

The Biggest Sun Myth Ever Told

Everything you’ve been told about skin cancer and the sun is a lie.

Outdoor workers get 3–10 times MORE sun exposure yet have LOWER melanoma rates than those stuck inside.

It gets worse.

A 20-year Swedish study found that avoiding sunlight raised the risk of premature death by 60%, especially from heart disease and cancer.

They pushed sunscreen and fear while ignoring the simple truth that sun exposure mostly causes HARMLESS cancers, while sun avoidance is linked to the DEADLIEST ones.

Get ready to be re-educated about the sun. It’s time to unlearn the lies you’ve been sold.

Ever wonder why you were told to hide from the sun?

It was never about your health.

Sunlight regulates circadian rhythms, lifts your mood, drives blood flow, and lowers your risk of dying.

And yet dermatology declared war on it—turning life-giving light into a deadly threat while skin cancer diagnoses soared.

Keep reading

Pharoah’s Curse Fungus Yields Breakthrough in Blood Cancer Treatment

In a stunning discovery, researchers at the University of Pennsylvania have harnessed a deadly fungus, once blamed for the “Pharaoh’s Curse,” to develop a promising new treatment for blood cancer.

This breakthrough, rooted in a toxin produced by the Aspergillus flavus mold, could offer hope to patients battling leukemia.

The story begins in the 1920s, when famed archaeologist Howard Carter opened King Tutankhamun’s tomb, an event followed by the mysterious deaths of eight team members. Whispers of a “Pharaoh’s Curse” spread, but medical experts suspected a fungal culprit.

Decades later, the excavation of King Casimir IV of Poland’s tomb in the 1970s confirmed these suspicions. Four of twelve archaeologists died within weeks, and investigators pinpointed Aspergillus flavus, a highly toxic fungus, as the cause. This mold produces asperigimycin, a toxin lethal to lung tissue but now showing remarkable potential in cancer research.

The University of Pennsylvania team discovered that asperigimycin is exceptionally effective at destroying leukemia cells in lab tests. However, the toxin required modification to become a viable cancer therapy.

Using a cutting-edge technique known as ribosomally synthesized and post-translationally modified peptides (RiPPs), the researchers engineered asperigimycin peptides.

Keep reading